BioSpace News Archive

Drug Development

Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP

Met primary endpoint of Early Clinical Response at 96 hours after the first dose

November 12, 2018
·
13 min read
Drug Development

THERANEXUS ANNOUNCES INCLUSION OF LAST PATIENT IN PHASE II TRIAL OF DRUG CANDIDATE THN102 ON NARCOLEPSY PATIENTS

Theranexus announces today that it has recruited the last patient in its Phase II trial, entitled “Tolerance and Efficacy of THN102 on Sleepiness in Narcoleptic Patients”.

November 12, 2018
·
2 min read
Business

Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results and Corporate Update

Ultragenyx Pharmaceutical Inc. today announced that it will host a conference call on Monday, November 5, 2018 at 5pm ET to discuss third quarter 2018 financial results and provide a corporate update.

November 12, 2018
·
1 min read
Business

A New Environment for Repairing Eyes

UH Expert to Bring Consistency to Corneal Stem Cell Fate

November 12, 2018
·
3 min read
Deals

Well-Funded Unicorn Moderna Therapeutics Eyes $500 Million IPO

As a private company, Moderna has amassed a significant fortune of billions of dollars and a valuation of about $7 billion – all of this without any marketed product in the company’s field of messenger RNA (mRNA).

November 12, 2018
·
2 min read
·
Alex Keown
As Deadliest Strain Ravages Country, Four Experimental Ebola Vaccines to Be Deployed in the Congo

As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.

November 12, 2018
·
3 min read
·
Alex Keown
Drug Development

Deep Dive: Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game

Checkpoint inhibitors are only effective against inflamed tumors, called ‘hot’ tumors. Unfortunately, most tumors are ‘cold’ (not inflamed) and hide from the immune system by appearing to be too similar to normal cells.

November 12, 2018
·
10 min read
·
Chelsea Weidman Burke
Policy

Dubai Government Workshop and American Hospital Dubai organizes awareness campaign on breast cancer risk and prevention

Move part of effort to increase awareness and educate about preventive measures

November 12, 2018
·
1 min read
Business

The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year

The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology (SGO), and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the third year of their partnership supporting the annual National Race to End Women’s Cancer.

November 12, 2018
·
3 min read
Deals

Takeda Sets a Date for Shareholders to Vote for the $62 Billion Acquisition of Shire

Pharma giant Takeda Pharmaceutical is looking to begin 2019 with a bang – closing its $62 billion acquisition of Shire plc by Jan. 8. This morning Takeda announced that it will hold an investor vote next month on the planned acquisition in order to swiftly move and finalize the deal.

November 12, 2018
·
3 min read
·
Alex Keown